Biotech
MANCHESTER, NH: 360 Patients to Be Enrolled in Phase III Study at 10 Sites in Four Countries; BTI-320, a Non-Systemic Chewable Tablet, Represents a New Generation of Alpha Glycosidase Inhibitors
...
DUBLIN, IRELAND: Accretive Transaction Boosts Horizon's Transformation Into a Profitable Specialty Pharma Company Revised Corporate Structure Enhances Horizon's Organic Growth and Acquisition Strategy The Co ...
CEDAR KNOLLS, NJ: MYOS Exploring Potential Role of Myostatin Inhibiting Product on Glucose and Fat Metabolism
...
RESEARCH TRIANGLE PARK, NC: The Company Has Added State-of-the-Art Equipment That Will Further Enhance Manufacturing Functionality and Capability
...
PORTLAND, ME: Including World Dairy Expo -- The Largest Dairy Tradeshow in the World
...
Tuttlingen: BINDER ultra low temperature freezer - Excellent energy efficiency due to water cooling
...
HUNTSVILLE, AL: New Guide Provides Extensive Information for Researchers Working on Autoimmune Disorders
...
